Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000592910 | SCV000708189 | uncertain significance | not provided | 2017-05-02 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001279283 | SCV001466366 | uncertain significance | Meckel syndrome, type 1 | 2020-08-14 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004732962 | SCV005367380 | uncertain significance | MKS1-related disorder | 2024-04-03 | no assertion criteria provided | clinical testing | The MKS1 c.579C>G variant is predicted to result in the amino acid substitution p.Asn193Lys. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |